Heidelberg Engineering focused on the expected burden glaucoma care could have on healthcare in the next decade at its first International Glaucoma Symposium on February 1.
Held at the University Eye Clinic in Mainz, Germany, the event welcomed delegates from 13 countries who discussed the safe integration of artificial intelligence (AI) into care pathways.
Dr Stephan Schulz, clinical director of glaucoma at Heidelberg Engineering, said: ‘Global experts explored the transformative role of AI in ophthalmology, clinical practice and research. This included optic neuropathies with a focus on glaucoma. The open forums were especially valuable for clinicians to discuss their concerns and the opportunities that AI brings in delivering care to a greater cohort of ageing patients.’
A presentation by Professors Norbert Pfeiffer and Esther Hofmann from Mainz University explored AI’s potential in optic neuropathies.
They highlighted that AI has the potential to enhance, not replace clinicians by improving diagnosis, early detection, personalised treatment and patient outcomes.
